Novavax Return On Tangible Assets from 2010 to 2024

NVAX Stock  USD 8.47  0.43  5.35%   
Novavax Return On Tangible Assets yearly trend continues to be fairly stable with very little volatility. Return On Tangible Assets will likely drop to -0.34 in 2024. Return On Tangible Assets is a profitability metric that measures a company's ability to generate earnings from its tangible assets. View All Fundamentals
 
Return On Tangible Assets  
First Reported
2010-12-31
Previous Quarter
(0.33)
Current Value
(0.34)
Quarterly Volatility
0.31494223
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Novavax financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Novavax's main balance sheet or income statement drivers, such as Depreciation And Amortization of 43.3 M, Interest Expense of 15.1 M or Selling General Administrative of 499.1 M, as well as many indicators such as Price To Sales Ratio of 0.47, Dividend Yield of 0.0066 or Days Sales Outstanding of 82.31. Novavax financial statements analysis is a perfect complement when working with Novavax Valuation or Volatility modules.
  
Check out the analysis of Novavax Correlation against competitors.
For more information on how to buy Novavax Stock please use our How to Invest in Novavax guide.

Latest Novavax's Return On Tangible Assets Growth Pattern

Below is the plot of the Return On Tangible Assets of Novavax over the last few years. It is a profitability metric that measures a company's ability to generate earnings from its tangible assets. Novavax's Return On Tangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Novavax's overall financial position and show how it may be relating to other accounts over time.
Return On Tangible Assets10 Years Trend
Pretty Stable
   Return On Tangible Assets   
       Timeline  

Novavax Return On Tangible Assets Regression Statistics

Arithmetic Mean(0.61)
Coefficient Of Variation(51.87)
Mean Deviation0.27
Median(0.49)
Standard Deviation0.31
Sample Variance0.1
Range0.9394
R-Value0.18
Mean Square Error0.10
R-Squared0.03
Significance0.53
Slope0.01
Total Sum of Squares1.39

Novavax Return On Tangible Assets History

2024 -0.34
2023 -0.33
2022 -0.31
2021 -0.71
2020 -0.3
2019 -1.12
2018 -1.24

About Novavax Financial Statements

Novavax investors use historical fundamental indicators, such as Novavax's Return On Tangible Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Novavax. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.33)(0.34)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Novavax Stock Analysis

When running Novavax's price analysis, check to measure Novavax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novavax is operating at the current time. Most of Novavax's value examination focuses on studying past and present price action to predict the probability of Novavax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novavax's price. Additionally, you may evaluate how the addition of Novavax to your portfolios can decrease your overall portfolio volatility.